Pen­to­statin CAS 53910-25-1

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions and Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

53910-25-1

Name

Pen­to­statin

Syn­onyms

(8R)-3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol [ACD/IUPAC Name] (8R)-3-(2-Desoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol [Ger­man] [ACD/IUPAC Name] (8R)-3-(2-Désoxy-β-D-érythro-pentofuranosyl)-3,4,7,8-tétrahydroimidazo[4,5-d][1,3]diazépin-8-ol [French] [ACD/IUPAC Name] (8R)-3-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxyméthyl)tétrahydrofuran-2-yl]-3,6,7,8-tétrahydroimidazo[4,5-d][1,3]diazépin-8-ol (R)-3-(2-Deoxy-b-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (R)-3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol CO-Vidara­bine DCF deoxy­co­formycin Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)- Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)- Imidazo[4,5-d][1,3]diazepin-8-ol, 3- (2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8- tetrahy­­dro-, (R)- Imidazo[4,5-d][1,3]diazepin-8-ol, 3- (2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)- Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)- Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (8R)- [ACD/​Index Name] PD-ADI (8R)-3-(2-deoxy-?-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-imidazo[4,5-d][1,3]diazepin-8-ol (8R)-3-(2-Deoxy-b-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (8R)-3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-imidazo[4,5-d][1,3]diazepin-8-ol (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol (R)-3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol (R,Z)-3,6,7,8-tetrahydro-3-((2R,4S,5R)-tetrahydro-4-hydroxy-5-(hydroxymethyl)furan-2-yl)imidazo[4,5-d][1,3]diazepin-8-ol [53910-25-1] 2′-DCF 2′-Deoxycoformycin 2′-deoxycoformycin|deoxycoformycin|Nipent® 2′-Dexoycoformycin 53910-25-1 [RN] Coforin Covi­dara­bine Co-vidara­bine ; Pen­to­statin ; Pen­to­stati­na ; Pen­to­sta­tine ; Pen­to­stat­inum Deoxy­co­formycin | Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)- MFCD00078802 [MDL num­ber] NI2931000 Nipent [Trade name] Nipent® Oncopent Pen­to­statin [Wiki] Pen­to­statin (JAN/USAN) [JAN] [USAN] Pen­to­stati­na Pen­to­sta­tine Pen­to­stat­inum Tox­ic Sol­id, Organ­ic, N.O.S. (Pen­to­statin) UN 2811 UN2811 UNII-395575M­­ZO7 Vidar­bine

Mol­e­c­u­lar Structure

SMILES

c1nc2c(n1[C@H]3C[C@@H]([C@H](O3)CO)O)N=CNC[C@H]2O

Std­InChI

InChI=1S/C11H16N4O4/c16-3-8-6(17)1-9(19-8)15-5-14-10-7(18)2-12-4-13-11(10)15/h4-9,16-18H,1-3H2,(H,12,13)/t6-,7+,8+,9+/m0/s1

Std­InChIKey

FPVKHB­SQE­­SCIEP-JQCXWYLXSA-N

Mol­e­c­u­lar Formula

C11H16N4O4

Mol­e­c­u­lar Weight

268.27

Prop­er­ties

Appear­ance

Off white or white crys­talline pow­der

Melt­ing Point

220～225℃

Safe­ty Data

Sym­bol

GHS06

Sig­nal Word

Dan­ger

Haz­ard Statements

H301

Pre­cau­tion­ary Statements

P301 + P310

RIDADR

UN 2811 6.1 / PGI­II

WGK Germany

3 

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Pen­to­statin CAS 53910-25-1 

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HNMR/HPLC

Puri­ty

98%min

Spe­cif­ic Opti­cal Rotation

≥+73.6°

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as phar­ma­ceu­ti­cal raw mate­ri­als, main­ly used as anti-tumor and anti-can­cer drugs

Links

This prod­uct is devel­oped by our RandD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​p​e​n​t​o​s​t​a​t​i​n​-​c​a​s​-​5​3​9​1​0​-​2​5​-1/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).  andD pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.